2016 Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Robin M Journal Bone Marrow Transplant.
2016 Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Sobh M Journal Leukemia
2016 Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal N Engl J Med.
2016 Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research. Group Chronic Malignancies Working Party (CMWP) 1st listed author Potter VT Journal Biol Blood Marrow Transplant.
2016 Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Koenecke C Journal Bone Marrow Transplant.
2015 Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Ruutu T Journal Bone Marrow Transplant.
2015 Efficacy and outcome of allogeneic transplantation in IgD and non secretory myeloma. A report on behalf of the myeloma subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Morris C Journal Biol Blood Marrow Transplant.
2015 Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal Blood
2015 Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial. Group Chronic Malignancies Working Party (CMWP) 1st listed author Iacobelli S Journal Bone Marrow Transplant.
2015 Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multigenerational study of the European Society of Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Koenecke C Journal Haematologica
2015 Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger NM Journal Leukemia
2014 Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years. Group Chronic Malignancies Working Party (CMWP) 1st listed author Auner HW Journal Bone Marrow Transplant.